Sedana Medical: A blow to the share but relatively non-affecting the case - Redeye

Redeye argues that the changed financial target is relatively unaffecting the long-term case for Sedana Medical. Our estimate changes do not affect our US estimates, which make up a large chunk of the fundamental value. Hence, we only make small changes to our fair value range.

Länk till analysen i sin helhet: https://www.redeye.se/research/840183/sedana-medical-a-blow-to-the-share-but-relatively-non-affecting-the-case?utm_source=finwire&utm_medium=RSS